Literature DB >> 10503710

A necessary role for reduced intracellular potassium during the DNA degradation phase of apoptosis.

J W Montague1, C D Bortner, F M Hughes, J A Cidlowski.   

Abstract

Apoptosis is a highly organized mechanism that allows specific cells to die in a controlled manner. Apoptosis can be induced by a variety of agents in a great number of cell types, but cell shrinkage and discrete chromatin cleavage remain common components of apoptosis that is manifested by constitutive enzymes. Despite intensive investigation, the actual event or events that signal this cell death process have not been completely identified. Because of their ability to effect a great number of cellular enzymes simultaneously, we have hypothesized that ions in high concentration (150 mM) in living cells may act as a repressor of apoptotic effectors. In this manuscript we review data that shows that DNA degradation only occurs in the shrunken population of lymphocytes treated with glucocorticoid, shrunken cells loose K+ and become hypotonic, and physiological concentrations on K+ inhibit nuclease activity irrespective of proteins. Together, these data suggest that the reduction in potassium levels appears necessary for the DNA degradation that occurs during apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503710     DOI: 10.1016/s0039-128x(99)00034-3

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  14 in total

Review 1.  K+ channels in apoptosis.

Authors:  E D Burg; C V Remillard; J X-J Yuan
Journal:  J Membr Biol       Date:  2006-04-17       Impact factor: 1.843

2.  Low K+ promotes NF-kappaB/DNA binding in neuronal apoptosis induced by K+ loss.

Authors:  Yanmei Tao; Dong Yan; Qiaoyun Yang; Rui Zeng; Yizheng Wang
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  Disruption of KV2.1 somato-dendritic clusters prevents the apoptogenic increase of potassium currents.

Authors:  Jason A Justice; Anthony J Schulien; Kai He; Karen A Hartnett; Elias Aizenman; Niyathi H Shah
Journal:  Neuroscience       Date:  2017-04-28       Impact factor: 3.590

4.  Effects of chloride and potassium channel blockers on apoptotic cell shrinkage and apoptosis in cortical neurons.

Authors:  Ling Wei; Ai Ying Xiao; Chun Jin; Aizhen Yang; Zhong Yang Lu; Shan Ping Yu
Journal:  Pflugers Arch       Date:  2004-04-01       Impact factor: 3.657

Review 5.  Ion channels in regulated cell death.

Authors:  Karl Kunzelmann
Journal:  Cell Mol Life Sci       Date:  2016-04-18       Impact factor: 9.261

6.  Convergent Ca2+ and Zn2+ signaling regulates apoptotic Kv2.1 K+ currents.

Authors:  Meghan C McCord; Elias Aizenman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

7.  Pseudomonas aeruginosa activates Cl- channels in host epithelial cells.

Authors:  Susanne Ullrich; Susanne Berchtold; Christoph Boehmer; Sophie Fillon; Verena Jendrossek; Monica Palmada; Torsten H Schroeder; Gerald B Pier; Florian Lang
Journal:  Pflugers Arch       Date:  2003-08-13       Impact factor: 3.657

8.  Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion.

Authors:  Christina Birka; Philipp A Lang; Daniela S Kempe; Lena Hoefling; Valerie Tanneur; Christophe Duranton; Srinivas Nammi; Guido Henke; Svetlana Myssina; Maxim Krikov; Stephan M Huber; Thomas Wieder; Florian Lang
Journal:  Pflugers Arch       Date:  2004-05-20       Impact factor: 3.657

9.  Enhancement of TWIK-related acid-sensitive potassium channel 3 (TASK3) two-pore domain potassium channel activity by tumor necrosis factor α.

Authors:  Mickael-F El Hachmane; Kathryn A Rees; Emma L Veale; Vadim V Sumbayev; Alistair Mathie
Journal:  J Biol Chem       Date:  2013-12-04       Impact factor: 5.157

10.  Molecular Neuroprotection Induced by Zinc-Dependent Expression of Hepatitis C-Derived Protein NS5A Targeting Kv2.1 Potassium Channels.

Authors:  Jason A Justice; Daniel T Manjooran; Chung-Yang Yeh; Karen A Hartnett-Scott; Anthony J Schulien; Gabrielle J Kosobucki; Shalom Mammen; Michael J Palladino; Elias Aizenman
Journal:  J Pharmacol Exp Ther       Date:  2018-09-06       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.